Forward Pharma A/S - ADR Financials

$2.56

$0.00 (0.00%)

As on 28-Feb-2023 09:30EDT

Market cap

$14 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	--	--	1,250.00
Cost of Revenue	--	--	--	--	--	25.00
Gross Profit	--	--	--	--	--	1,225.00
Operating Expenses	--	3.87	3.39	5.28	12.28	37.60
Operating Profit (EBIT)	--	-3.87	-3.39	-5.28	-12.28	1,187.40
Other Income	--	--	--	--	--	--
Profit before Tax	--	-1.89	-6.45	-4.22	-8.93	1,184.49
Provision for Tax	--	--	--	--	-0.20	267.40
Profit after Tax (Net Income)	--	-1.89	-6.45	-4.22	-8.72	917.09
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-0.57	-1.89	-6.45	-4.22	-8.72	917.09

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	62.08	70.80	78.64	77.57	82.21	89.68
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	--	0.04
Current Liabilities	3.56	0.61	1.07	0.60	1.12	21.29
Total Liabilities	69.21	71.41	79.71	78.17	83.33	111.01

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	0.00	0.00	0.00	0.00	0.00	0.02
Current Assets	65.64	71.40	79.71	78.16	83.33	110.99
Total Assets	69.21	71.41	79.71	78.17	83.33	111.01
Total Debt*	--	--	--	--	--	--
Net Current Assets	62.08	70.79	78.64	77.57	82.21	89.71

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-2.36	-5.71	-2.23	-14.79	939.95
Cash Flow from Investing Activities	--	--	0.00	0.00	0.00	85.37
Cash from Financing Activities	--	0.00	-0.28	-0.80	-8.12	-1,118.69
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-2.53	-8.26	-5.28	-10.15	747.18
ROE (%)	--	-2.53	-8.26	-5.28	-10.15	747.18
ROA (%)	--	-2.50	-8.17	-5.23	-8.98	669.04
EBIT Margin (%)	--	--	--	--	--	94.76
Net Margin (%)	--	--	--	--	--	73.37
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	--	--	-1.00	--
EBIT Growth (%)	-21.43	-14.41	19.78	52.71	-100.75	2,271.82
Net Profit Growth (%)	--	70.66	-52.78	51.61	-100.95	2,851.06
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.31	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	16.96	37.40	12.26	18.39	9.25	-0.09
Close Price ($)	4.50	5.97	7.03	6.49	5.46	25.76
High Price ($)	20.31	20.31	12.72	11.48	40.25	231.00
Low Price ($)	4.02	5.37	4.61	5.26	4.97	21.28
Market Cap ($ Cr)	13.83	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	18.43	117.44	74.50	131.15	74.53	5.21
Quick Ratio	18.43	--	--	--	--	--
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	0.07
Asset Turnover	--	--	--	--	--	9.12
Receivable days	--	--	--	--	--	0.20
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	23.93
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.